• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌患者癌症相关认知障碍的风险因素:系统评价和荟萃分析。

Risk factors for cancer-related cognitive impairment among individuals with lung cancer: a systematic review and meta-analysis.

机构信息

Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.

Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, China.

出版信息

Support Care Cancer. 2024 Sep 17;32(10):663. doi: 10.1007/s00520-024-08873-w.

DOI:10.1007/s00520-024-08873-w
PMID:39287692
Abstract

OBJECTIVES

Cancer-related cognitive impairment (CRCI) exerts a negative impact on the quality of life in lung cancer survivors. Risk factors for CRCI in lung cancer patients remain unclear.This study aimed to identify risk factors for CRCI in lung cancer patients.

METHODS

A comprehensive literature search was conducted across PubMed, CINAHL, Web of Science, Wanfang, VIP Database, Embase, and China National Knowledge Infrastructure (CNKI) from their inception until March 10, 2024. Studies were screened, data extracted, and quality assessed using the Agency for Healthcare Research and Quality and Newcastle-Ottawa Scale. Meta-analysis was performed using RevMan 5.4, assessing risk factors through odds ratios (OR) with 95% confidence intervals (CIs).

RESULTS

The analysis was comprised of nine studies, including 1,305 patients. Seven studies were high quality, and two were moderate quality. Identified risk factors for CRCI in lung cancer patients included advanced age (OR = 3.51, 95%CI: 2.14-5.74, I = 0.0%), cranial irradiation (OR = 2.12, 95% CI: 1.39-3.22, I = 0.0%), anxiety (OR = 2.92, 95% CI: 1.65-5.25, I = 37%), and symptom cluster burden (OR = 4.85, 95% CI: 2.99-7.87, I = 0.0%). Physical activity (OR = 0.37, 95% CI; 0.23-0.58, I = 9.0%) was identified as a protective factor.

CONCLUSION

Advanced age, cranial irradiation, anxiety, and symptom cluster burden are significant risk factors for CRCI, while physical activity serves as a protective factor. These insights provide healthcare professionals with an evidence-based framework for managing CRCI in lung cancer patients.

摘要

目的

癌症相关认知障碍(CRCI)会降低肺癌幸存者的生活质量。肺癌患者发生 CRCI 的危险因素尚不清楚。本研究旨在确定肺癌患者发生 CRCI 的危险因素。

方法

从建库至 2024 年 3 月 10 日,通过 PubMed、CINAHL、Web of Science、万方、维普、Embase 和中国知网(CNKI)全面检索文献。采用美国卫生保健研究与质量局和纽卡斯尔-渥太华量表筛选、提取和评价数据。采用 RevMan 5.4 进行荟萃分析,采用比值比(OR)及其 95%置信区间(CI)评估危险因素。

结果

分析纳入 9 项研究,共 1305 例患者。其中 7 项研究质量较高,2 项研究质量中等。肺癌患者发生 CRCI 的危险因素包括高龄(OR=3.51,95%CI:2.14-5.74,I²=0.0%)、颅脑放疗(OR=2.12,95%CI:1.39-3.22,I²=0.0%)、焦虑(OR=2.92,95%CI:1.65-5.25,I²=37%)和症状群负担(OR=4.85,95%CI:2.99-7.87,I²=0.0%)。身体活动(OR=0.37,95%CI:0.23-0.58,I²=9.0%)是保护因素。

结论

高龄、颅脑放疗、焦虑和症状群负担是 CRCI 的显著危险因素,而身体活动是保护因素。这些发现为临床医护人员提供了管理肺癌患者 CRCI 的循证框架。

相似文献

1
Risk factors for cancer-related cognitive impairment among individuals with lung cancer: a systematic review and meta-analysis.肺癌患者癌症相关认知障碍的风险因素:系统评价和荟萃分析。
Support Care Cancer. 2024 Sep 17;32(10):663. doi: 10.1007/s00520-024-08873-w.
2
Prevalence and assessment tools of cancer-related cognitive impairment in lung cancer survivors: a systematic review and proportional meta-analysis.肺癌幸存者中与癌症相关的认知障碍的患病率和评估工具:系统评价和比例荟萃分析。
Support Care Cancer. 2024 Mar 5;32(4):209. doi: 10.1007/s00520-024-08402-9.
3
Cancer-related cognitive impairment: updates to treatment, the need for more evidence, and impact on quality of life-a narrative review.癌症相关认知障碍:治疗进展、更多证据需求及对生活质量的影响——一篇叙述性综述。
Ann Palliat Med. 2024 Sep;13(5):1265-1280. doi: 10.21037/apm-24-70. Epub 2024 Sep 9.
4
Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.老年乳腺癌幸存者化疗相关认知障碍的患病率及相关因素。
J Adv Nurs. 2024 Feb;80(2):484-499. doi: 10.1111/jan.15842. Epub 2023 Sep 7.
5
Factors associated with cancer-related cognitive impairment in patients with lung cancer: A systematic review.与肺癌患者癌症相关认知障碍相关的因素:系统评价。
Eur J Oncol Nurs. 2024 Aug;71:102657. doi: 10.1016/j.ejon.2024.102657. Epub 2024 Jul 1.
6
Effective non-pharmacological interventions for cancer related cognitive impairment in adults (excluding central nervous system or head and neck cancer): systematic review and meta-analysis.成人癌症相关认知障碍的有效非药物干预措施(不包括中枢神经系统或头颈部癌症):系统评价和荟萃分析。
Eur J Phys Rehabil Med. 2022 Apr;58(2):258-270. doi: 10.23736/S1973-9087.21.06898-2. Epub 2021 Sep 9.
7
The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.常见癌症相关认知障碍的体验:定性系统评价方案。
JMIR Res Protoc. 2024 May 31;13:e56888. doi: 10.2196/56888.
8
Cognitive functioning and work-related outcomes of non-central nervous system cancer survivors: protocol for a systematic review with meta-analysis.非中枢神经系统癌症幸存者的认知功能和与工作相关的结局:系统评价和荟萃分析的方案。
BMJ Open. 2022 Jul 12;12(7):e060300. doi: 10.1136/bmjopen-2021-060300.
9
The high burden of symptoms associated with cognitive impairment in lung cancer patients: A latent class analysis.肺癌患者认知障碍相关症状的高负担:一项潜在类别分析。
Asia Pac J Oncol Nurs. 2023 Feb 6;10(4):100200. doi: 10.1016/j.apjon.2023.100200. eCollection 2023 Apr.
10
Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review.青少年及年轻成年期非中枢神经系统癌症幸存者的癌症相关认知障碍:范围综述。
Psychooncology. 2022 Aug;31(8):1275-1285. doi: 10.1002/pon.5980. Epub 2022 Jul 7.

引用本文的文献

1
Establishment and validation of a risk prediction model for postoperative persistent cough in lung resection patients: a systematic review and meta-analysis-based approach.肺切除患者术后持续性咳嗽风险预测模型的建立与验证:基于系统评价和荟萃分析的方法
J Thorac Dis. 2025 Jul 31;17(7):4758-4767. doi: 10.21037/jtd-2025-440. Epub 2025 Jul 29.
2
Prevalence and Predictors of Chemotherapy-Related Cognitive Impairment in Elderly Lung Cancer Patients: A Cross-Sectional Study.老年肺癌患者化疗相关认知障碍的患病率及预测因素:一项横断面研究
Brain Behav. 2025 Jun;15(6):e70594. doi: 10.1002/brb3.70594.

本文引用的文献

1
Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.老年乳腺癌幸存者化疗相关认知障碍的患病率及相关因素。
J Adv Nurs. 2024 Feb;80(2):484-499. doi: 10.1111/jan.15842. Epub 2023 Sep 7.
2
Checkpoint inhibitors in older patients with advanced non-small cell lung cancer.检查点抑制剂在晚期非小细胞肺癌老年患者中的应用。
Crit Rev Oncol Hematol. 2023 Aug;188:104056. doi: 10.1016/j.critrevonc.2023.104056. Epub 2023 Jun 9.
3
The high burden of symptoms associated with cognitive impairment in lung cancer patients: A latent class analysis.
肺癌患者认知障碍相关症状的高负担:一项潜在类别分析。
Asia Pac J Oncol Nurs. 2023 Feb 6;10(4):100200. doi: 10.1016/j.apjon.2023.100200. eCollection 2023 Apr.
4
Cancer-related Fatigue in Lung Cancer: A Research Agenda: An Official American Thoracic Society Research Statement.肺癌相关疲劳:研究议程:美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2023 Mar 1;207(5):e6-e28. doi: 10.1164/rccm.202210-1963ST.
5
Effectiveness of mindfulness-based interventions on anxiety, depression, and fatigue in people with lung cancer: A systematic review and meta-analysis.基于正念的干预措施对肺癌患者焦虑、抑郁和疲劳的有效性:一项系统评价和荟萃分析。
Int J Nurs Stud. 2023 Apr;140:104447. doi: 10.1016/j.ijnurstu.2023.104447. Epub 2023 Jan 30.
6
Neurocognitive functioning following lung cancer treatment: The PRO-Long Study.肺癌治疗后的神经认知功能:PRO-Long研究。
Tech Innov Patient Support Radiat Oncol. 2022 Feb 16;21:36-40. doi: 10.1016/j.tipsro.2022.02.004. eCollection 2022 Mar.
7
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?化疗和免疫疗法的认知不良反应:干预措施是否可行?
Nat Rev Neurol. 2022 Mar;18(3):173-185. doi: 10.1038/s41582-021-00617-2. Epub 2022 Feb 9.
8
Neuropsychological Interventions for Cancer-Related Cognitive Impairment: A Network Meta-Analysis of Randomized Controlled Trials.癌症相关认知障碍的神经心理学干预:随机对照试验的网络荟萃分析。
Neuropsychol Rev. 2022 Dec;32(4):893-905. doi: 10.1007/s11065-021-09532-1. Epub 2022 Jan 29.
9
Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.随机 III 期临床试验:预防性全脑放疗联合或不联合海马回避治疗小细胞肺癌(PREMER):GICOR-GOECP-SEOR 研究。
J Clin Oncol. 2021 Oct 1;39(28):3118-3127. doi: 10.1200/JCO.21.00639. Epub 2021 Aug 11.
10
Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.肺癌患者神经元自身抗体与认知障碍的相关性。
JAMA Oncol. 2021 Sep 1;7(9):1302-1310. doi: 10.1001/jamaoncol.2021.2049.